CONDENSED CONSOLIDATED GUARANTOR FINANCIAL INFORMATION (Details 3) (USD $) In Thousands, unless otherwise specified	2 Months Ended	3 Months Ended	6 Months Ended	2 Months Ended	3 Months Ended	6 Months Ended	2 Months Ended	3 Months Ended	6 Months Ended	2 Months Ended	3 Months Ended	6 Months Ended	1 Months Ended	4 Months Ended		1 Months Ended	4 Months Ended	1 Months Ended	4 Months Ended	1 Months Ended	4 Months Ended
	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2012	Jun. 30, 2011 Parent Company Angiotech Pharmaceuticals, Inc.	Jun. 30, 2012 Parent Company Angiotech Pharmaceuticals, Inc.	Jun. 30, 2012 Parent Company Angiotech Pharmaceuticals, Inc.	Jun. 30, 2011 Guarantor Subsidiaries	Jun. 30, 2012 Guarantor Subsidiaries	Jun. 30, 2012 Guarantor Subsidiaries	Jun. 30, 2011 Non Guarantor Subsidiaries	Jun. 30, 2012 Non Guarantor Subsidiaries	Jun. 30, 2012 Non Guarantor Subsidiaries	Apr. 30, 2011 Predecessor	Apr. 30, 2011 Predecessor	Jun. 30, 2011 Predecessor	Apr. 30, 2011 Predecessor Parent Company Angiotech Pharmaceuticals, Inc.	Apr. 30, 2011 Predecessor Parent Company Angiotech Pharmaceuticals, Inc.	Apr. 30, 2011 Predecessor Guarantor Subsidiaries	Apr. 30, 2011 Predecessor Guarantor Subsidiaries	Apr. 30, 2011 Predecessor Non Guarantor Subsidiaries	Apr. 30, 2011 Predecessor Non Guarantor Subsidiaries
OPERATING ACTIVITIES:
Cash used in operating activities before reorganization items	$ 7,857	$ 23,361	$ 35,231	$ (2,826)	$ 12,181	$ 12,000	$ 7,012	$ 6,430	$ 16,568	$ 2,313	$ 4,750	$ 6,663	$ 1,806	$ (1,420)		$ (998)	$ (7,900)	$ 288	$ 2,887	$ 2,516	$ 3,593
OPERATING CASH FLOWS FROM REORGANIZATION ACTIVITIES
Professional fees paid for services rendered in connection with the Creditor Protection Proceedings	(8,105)			(8,105)									(3,095)	(10,055)		(3,095)	(7,447)		(2,608)
Key Employment Incentive Plan fee	(551)			(156)			(395)
Director's and officer's insurance														(1,382)			(1,382)
Cash used in reorganization activities	(8,656)			(8,261)			(395)						(3,095)	(11,437)		(3,095)	(8,829)		(2,608)
Cash provided by (used in) operating activities	(799)	23,361	35,231	(11,087)	12,181	12,000	6,617	6,430	16,568	2,313	4,750	6,663	(1,289)	(12,857)		(4,093)	(16,729)	288	279	2,516	3,593
INVESTING ACTIVITIES:
Purchase of property, plant and equipment	(385)	(436)	(849)	(97)	(37)	(56)	(288)	(335)	(669)		(64)	(124)	(142)	(945)		(29)	(329)	(113)	(591)		(25)
Proceeds from disposition of property, plant and equipment	2,624	400	976	1,732		576	892	400	400
Proceeds from disposition of short term investments		1,150	2,272		1,150	2,272
Cash provided by (used in) investing activities	2,239	1,114	2,399	1,635	1,113	2,792	604	65	(269)		(64)	(124)	(142)	(945)		(29)	(329)	(113)	(591)		(25)
FINANCING ACTIVITIES:
Share capital issued		(881)	(881)		(881)	(881)								1			1
Deferred financing charges and costs	(1,358)	(474)	(824)					(474)	(824)				(50)	(1,278)				(50)	(1,278)
Dividends received / (paid)							1,500	1,500	3,000	(1,500)	(1,500)	(3,000)						2,137	3,137	(2,137)	(3,137)
Net (repayments) advances on Revolving Credit Facility	(7,542)		(39)				(7,542)		(39)				5,000	12,018				5,000	12,018
Proceeds from stock options exercised		0	0
Intercompany notes payable/receivable				10,826	325	(1,763)	(10,826)	(325)	1,763							3,789	10,967	(3,789)	(10,967)
Cash (used in) provided by financing activities before reorganization activities	(8,900)	(1,355)	(1,744)	10,826			(16,868)			(1,500)
FINANCING CASH FLOWS FROM REORGANIZATION ACTIVITIES
Deferred financing costs	(1,408)			(1,408)
Cash (used in) provided by financing activities	(10,308)	(1,355)	(1,744)	9,418	(556)	(2,644)	(16,868)	701	3,900	(1,500)	(1,500)	(3,000)	4,950	10,741		3,789	10,968	3,298	2,910	(2,137)	(3,137)
Effect of exchange rate changes on cash and cash equivalents	283	(202)	(68)							283	(202)	(68)	(208)	(32)						(208)	(32)
Net increase (decrease) in cash and cash equivalents	(8,585)	22,918	35,818	(34)	12,738	12,148	(9,647)	7,196	20,199	1,096	2,984	3,471	3,311	(3,093)		(333)	(6,090)	3,473	2,598	171	399
Cash and cash equivalents, beginning of period	30,222	35,073	22,173	5,090	8,059	8,649	18,132	20,452	7,449	7,000	6,562	6,075	26,911	33,315	21,637	5,423	11,180	14,659	15,340	6,829	6,795
Cash and cash equivalents, end of period	$ 21,637	$ 57,991	$ 57,991	$ 5,056	$ 20,797	$ 20,797	$ 8,485	$ 27,648	$ 27,648	$ 8,096	$ 9,546	$ 9,546	$ 30,222	$ 30,222	$ 21,637	$ 5,090	$ 5,090	$ 18,132	$ 18,132	$ 7,000	$ 7,000